跳至主要内容
临床试验/NL-OMON20097
NL-OMON20097已完成不适用

Effect on bone turnover and BMD of low dose oral silicon as an adjunct to calcium/vitamin D3 in a randomized, placebo-controlled trial.

1. Twin Research and Genetic Epidemiology Unit, St Thomas’ Hospital, Kings College, London, United Kingdom;<br>2. Department of Pharmaceutical Sciences, Faculty of Pharmaceutical, Biomedical and Veterinary Sciences, University of Antwerp, Antwerp, Belgium;<br>3. MRC Human Nutrition Research, Elsie Widdowson Laboratory, Cambridge, United Kingdom.0 个研究点目标入组 184 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
184

研究概览

简要总结

Journal of Bone and Mineral Research, Vol 20, Suppl 1, S172, SA 421, September 2005

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Osteopenic, but otherwise healthy;
  • 2. Caucasian women with a T-score < -1.5 at the lumbar spine by DEXA scan.

排除标准

  • 1. Patients were excluded according to the following criteria:
  • a. Renal failure as defined by serum creatinine > 200 µmol/L;

研究者

发起方
1. Twin Research and Genetic Epidemiology Unit, St Thomas’ Hospital, Kings College, London, United Kingdom;<br>2. Department of Pharmaceutical Sciences, Faculty of Pharmaceutical, Biomedical and Veterinary Sciences, University of Antwerp, Antwerp, Belgium;<br>3. MRC Human Nutrition Research, Elsie Widdowson Laboratory, Cambridge, United Kingdom.

相似试验